PLX8394 is an orally active inhibitor of serine/threonine-protein kinase B-Raf (BRAF) protein. PLX8394 can selectively bind to and inhibit the activity of both wild-type and mutated forms of BRAF, then inhibit the proliferation of tumor cells which express mutated forms of BRAF. PLX8394 appears to be effective against tumors that express multiple mutated forms of […]
More Information Supplier Page
Resmetirom (VIA-3196) is a highly selective thyroid hormone receptor β (THR-β) agonist.
More Information Supplier Page
Resmetirom (VIA-3196) is a highly selective thyroid hormone receptor β (THR-β) agonist.
More Information Supplier Page 
NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation.
More Information Supplier Page
NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation.
More Information Supplier Page NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation.
More Information Supplier Page NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation.
More Information Supplier Page Resmetirom (VIA-3196) is a highly selective thyroid hormone receptor β (THR-β) agonist.
More Information Supplier Page Resmetirom (VIA-3196) is a highly selective thyroid hormone receptor β (THR-β) agonist.
More Information Supplier Page 
ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.
More Information Supplier Page
